Latest Articles
11. 04. 2024
KLH-12 version 4
Requirements for Documentation Relating to Compliance with Good Manufacturing Practice in the Submission of Applications for Clinical Trial Authorisation
11. 04. 2024
KLH-19 version 3
Requirements on authorisation of clinical trials on medicinal products – data required for the pharmaceutical part of the documentation.
28. 03. 2024
List of reimbursed medicinal products valid as of 1.4.2024
Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List...
01. 03. 2024
Correction of the List of reimbursed medicinal products valid as of 1.3.2024
Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List...
29. 02. 2024
List of reimbursed medicinal products valid as of 1.3.2024
Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List...
31. 01. 2024
List of reimbursed medicinal products valid as of 1.2.2024
Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List...
29. 12. 2023
List of reimbursed medicinal products valid as of 1.1.2024
Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List...
cz
